drugset

drugset / Trial / NCT00884169

Study to Investigate the Efficacy and the Safety of M518101 in Psoriasis Patients

NCT00884169 ↗

Phase 2 Completed Maruho Co., Ltd.

RandomizedDouble-blind

Summary

This study is to investigate the efficacy and safety of M518101 in male and female plaque psoriasis patients with refractory plaques.

Timeline

Start: 2009-07
Primary completion: —
Completion: 2009-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	pefcalcitol	Small molecule	—	—

Indications